Co-Authors
This is a "connection" page, showing publications co-authored by Adanma Ayanambakkam and Kelly Stratton.
Connection Strength
0.587
-
Neoadjuvant/adjuvant relugolix and enzalutamide for the treatment of high-risk locally advanced prostate cancer: study protocol of the RENAPCA phase Ib trial. BMJ Open. 2026 Apr 24; 16(4):e112623.
Score: 0.249
-
Paradoxical Emergence of Cutaneous Squamous Cell Carcinoma During Pembrolizumab Treatment for Non-muscle Invasive Bladder Cancer and Subsequent Successful Therapeutic Adjustments. Cureus. 2025 Mar; 17(3):e80293.
Score: 0.230
-
Correction: A multidisciplinary approach to address unmet needs in the management of patients with non-metastatic castration-resistant prostate cancer. Prostate Cancer Prostatic Dis. 2024 Apr 20.
Score: 0.054
-
A multidisciplinary approach to address unmet needs in the management of patients with non-metastatic castration-resistant prostate cancer. Prostate Cancer Prostatic Dis. 2024 Mar 02.
Score: 0.054